For all the latest industry news, markets and jobs in aquaculture
Benchmark Holdings, parent to the Benchmark aquaculture biotechnology group, has raised NOK 158 million (£13m) in preparation for a listing on the Oslo Stock Exchange. The issue was priced at […] Continue Reading
Aquaculture biotechnology group Benchmark Holdings has seen a fifth consecutive quarter of growth in revenue and earnings, thanks partly to the successful roll-out of its CleanTreat sea lice solution. Benchmark […] Continue Reading
An accidental release of the new sea lice treatment Ectosan last month had a minimal impact on the marine environment, according to Benchmark Animal Health. The spill took place on […] Continue Reading
Aquaculture biotechnology company Benchmark Holdings is reorganising its marketing and commercial structure to create a combined Atlantic salmon portfolio. Sales and marketing, and commercial functions for clients in the salmon […] Continue Reading
Benchmark Animal Health and international salmon farmer Cermaq Group AS are to receive funding for a collaborative research project to develop a new vaccine against salmon diseases caused by Tenacibaculum […] Continue Reading
Aquaculture biotech group Benchmark has reported big increases in revenue and profit for the 2020/21 financial year. Revenue for the group’s parent, Benchmark Holdings, for the 12 months to 30 […] Continue Reading
Benchmark Animal Health’s novel sea lice treatment BMK08 has taken another step towards commercial roll-out, with a maximum residue limit (MRL) now ratified under European law. The MRL represents the […] Continue Reading
SCOTTISH innovation was celebrated on the opening day of the world’s number one aquaculture show, when Edinburgh based Benchmark won the prestigious Aqua Nor Innovation Award this morning. The company […] Continue Reading
BENCHMARK, the aquaculture health business, has reported a 65 per cent growth in its annual earnings before tax (EBITDA), to £16.5 million. In a trading update for the year ended […] Continue Reading